It is obvious people see value in MAKO.
Stryker thinks @ $30 per share, they can make money off this.
So, does MAKO need help, and what is their fair value?
I expected this could run 10x (or more) over the next five to ten years so 2x is extremely cheap. It wouldn't surprise me to see a bidding war but I wouldn't expect more than another 50% above the current bid.
Sentiment: Strong Buy
I don't understand. This thing has traded millions of shares the last 2 days, and the price hasn't fluctuated by more than a nickel. Are they just trading the same shares back and forth between themselves?
I wish. I really want it to be a stand-alone company. I really believed in this company and built a pretty good size holding, and I am disappointed that it will be owned by Stryker now. I do own a little Stryker, and I might buy more now. This will make Stryker the only deal in town for a hip replacement. They already have a good product, but this makes the placement accurate. The only possible bidder I would think would be Zimmer. Stryker knees are losing out to Smith and Nephew knees and I don't know if Smith and Nephew have a hip component or not.
Realistically, what would a "bidding war" get this to? Maybe$40?
I would personally hold out for 40 or more but the potential suitors at that level are slim. Not selling yet but not many options.